Kerala is a distinct market for any medicine distributor. Residents read labels, ask doctors questions and visit clinics early. The state also has the oldest population in India. That mix creates steady demand for prescription tablets, but it also rewards partners who choose products with care. This guide explains why Kerala suits a Tablets PCD Pharma Franchise in Kerala, what the latest 2026 data says, which tablet combinations fit local prescribing needs, and how to select a reliable partner. If you are comparing a PCD pharma franchise Company in India for your district, use this article as a checklist.

Why Kerala Is a Strong Market for Tablets

Three factors set Kerala apart from most other states.

An ageing population. The National Family Health Survey (NFHS-6) puts the share of Keralites aged 60 and above at 20.7%. That figure was 18.6% in the earlier 2019–21 round, and the national average stands at 12.9%. State projections expect seniors to form about 22.8% of the population by 2036.

A high chronic disease load. The Longitudinal Ageing Survey of India found that 34.75% of older adults in Kerala live with diabetes and 53.24% live with hypertension. NFHS-6 also shows rising obesity and blood sugar levels across both men and women in the state.

High health awareness. The 80th round of the National Sample Survey, released in April 2026, recorded more people reporting illness in Kerala than in any other state. Researchers link this to better diagnosis, greater awareness and an older population.

In short, patients in Kerala consult doctors often, and doctors prescribe often. Pain, nerve health, infection and allergy treatments all see regular use.

The Wider Picture: India’s Pharma Growth in 2026

Kerala’s demand sits inside a growing national market:

• India’s domestic pharma market stands near USD 60 billion in 2026 and may reach USD 130 billion by 2030.
• India ranks third in the world by volume and eleventh by value.
• Pharma exports reached USD 30.47 billion in FY 2024-25.
• ICRA projected 8–10% domestic growth for FY2026.

This growth helps new distributors. A franchise partner does not need a factory or a large team. The company manufactures and supplies the tablets, while the partner handles promotion and distribution in the assigned area.

How a PCD Franchise Works in Kerala

PCD stands for Propaganda cum Distribution. You receive exclusive rights to market a company’s brands in a defined area, such as Ernakulam, Thrissur, Kozhikode or the whole state. The manufacturer produces, packs and ships the tablets. You build relationships with doctors, hospitals and chemists.

The model suits Kerala for practical reasons:

• Doctors prefer representatives who visit regularly and explain composition clearly.
• Dense town networks make district-level coverage manageable.
• Chemists place repeat orders when products move steadily.

If you want your own label later, you can move to third party manufacturing after you understand local demand.

Tablet Range to Consider

Each name below links to a product page. These are prescription medicines. Doctors must decide when and how patients use them.

Pain and Muscle Spasm

Orthopaedic and general practitioners treat back pain, neck pain and joint stiffness daily.

• Aceclofenac 100 mg and Thiocolchicoside 4 mg tablets combine an anti-inflammatory with a muscle relaxant. Doctors use the Aceclofenac Thiocolchicoside pairing for painful spasm.
• Aceclofenac 200 mg SR tablets use a sustained-release design, which supports less frequent dosing in arthritis.
• Etoricoxib 60 mg and Thiocolchicoside 4 mg tablets pair a COX-2 selective NSAID with a muscle relaxant for acute low back pain.

Because Kerala has many older patients, prescribers check kidney function, stomach risk and heart history before choosing an NSAID. Keep that context in mind when you brief doctors.

Brain and Nerve Health

Citicoline 500 mg and Piracetam 800 mg tablets belong to the nootropic class. Neurologists and physicians prescribe the Citicoline Piracetam combination for memory complaints and recovery after stroke. With one in five Keralites aged 60 or above, this segment has clear relevance.

Infection Care

Kerala’s long monsoon and high humidity support respiratory, ear, throat, skin and urinary infections.

• Faropenem 200 mg tablets and Faropenem 300 mg tablets come from the penem class of antibiotics. Doctors select the strength by infection type and severity.
• Cefpodoxime 200 mg and Clavulanate 125 mg tablets add a beta-lactamase inhibitor to a cephalosporin. The Cefpodoxime Clavulanate pairing targets resistant bacteria.
• Cefuroxime Axetil 250 mg tablets offer a second-generation cephalosporin for respiratory and skin infections.

Antibiotic resistance is a serious concern. Promote these products only to qualified doctors, and encourage full-course use.

Allergy and Respiratory Relief

Bilastine 20 mg and Montelukast 10 mg tablets treat allergic rhinitis and chronic urticaria. Bilastine is a non-sedating antihistamine, while Montelukast blocks leukotrienes. Damp weather, mould and dust raise allergy complaints in coastal and hill districts alike.

Pregnancy Care

Doxylamine 20 mg, Pyridoxine 20 mg and Folic Acid 5 mg tablets address nausea and vomiting during pregnancy. Kerala records near-universal institutional deliveries, so gynaecologists see many antenatal patients and prescribe supportive combinations like this one.

Anti-Inflammatory Steroid

Methylprednisolone 16 mg tablets treat severe allergy, asthma flare-ups and inflammatory or autoimmune conditions. Steroids need medical supervision and a planned dose taper because side effects are real.

How to Choose Products for Your Kerala District

Do not launch every product on day one. Follow this sequence:

1. List your doctors. Count orthopaedic surgeons, physicians, gynaecologists, neurologists and chest specialists.
2. Match specialities to tablets. Pain tablets suit orthopaedic clinics. Pregnancy tablets suit gynaecologists. Antibiotics and allergy tablets suit physicians.
3. Plan around the monsoon. Stock infection and allergy tablets before June.
4. Begin with four to six products. Add more as your field team gains confidence.
5. Review monthly. Track repeat orders and drop slow movers.

Checklist Before You Sign

Verify these points with any PCD pharma franchise Company in India:

• A valid manufacturing licence and a GMP or WHO-GMP certificate
• Batch-wise certificates of analysis
• Written territory exclusivity
• Clear minimum order quantity and delivery time
• Packaging suited to humid climates, such as blister or alu-alu packs
• Visual aids, samples and literature for doctor visits

Ojana Pharmaceutical lists composition details for all eleven tablets on its product pages, so you can compare formulations before you enquire.

Compliance Basics in Kerala

Hold a valid drug licence for your premises. Store tablets in a cool, dry place and follow label directions. Maintain invoices and batch records. Market prescription medicines only to medical professionals. Kerala has an active drug regulatory system and informed patients, so clean records protect your business.

Final Thoughts

Kerala combines an ageing population, high chronic disease burden and strong health awareness. Those factors make it a serious market for a Tablets PCD Pharma Franchise in Kerala. Choose a verified partner, match products to local doctors, and expand gradually. Careful selection will serve you better than a long product list.

This article is for general information only. It is not medical advice. Doctors should decide the choice and dose of any medicine.

Frequently Asked Questions

1. Why is a Tablets PCD Pharma Franchise in Kerala a good business choice in 2026?

Kerala has the oldest population in India, with 20.7% of residents aged 60 or above in NFHS-6. Older patients need regular prescriptions, so a Tablets PCD Pharma Franchise in Kerala can generate steady, repeat demand.

2. Which tablets suit a Tablets PCD Pharma Franchise in Kerala?

Pain, nerve health, infection, allergy and pregnancy tablets match local needs. A Tablets PCD Pharma Franchise in Kerala often includes Aceclofenac with Thiocolchicoside, Citicoline with Piracetam and Bilastine with Montelukast.

3. How much investment does a Tablets PCD Pharma Franchise in Kerala need?

Investment varies by company, territory and product count. A Tablets PCD Pharma Franchise in Kerala costs less than a manufacturing unit, because the partner supplies stock rather than a factory. Ask each company for its minimum order value in writing.

4. What should I verify before joining a PCD pharma franchise Company in India for Kerala?

Check the manufacturing licence, GMP certificate, batch test reports and territory rights. Since India has over 3,000 pharma companies in 2026, these checks help a Tablets PCD Pharma Franchise in Kerala start on firm ground.

5. Does Kerala’s monsoon affect a Tablets PCD Pharma Franchise in Kerala?

Yes. Heavy rain raises infection and allergy cases, and humidity affects storage. A Tablets PCD Pharma Franchise in Kerala should stock seasonal products early and keep tablets in dry conditions.

6. Can I promote antibiotics under a Tablets PCD Pharma Franchise in Kerala?

You can promote them to qualified doctors only. Antibiotics are prescription medicines, and resistance remains a concern in 2026. A responsible Tablets PCD Pharma Franchise in Kerala supports rational use and full-course prescribing.

Sources and References

We collected the data in this article from the government releases and news reports below. Please check the original source again before you quote a figure in your own material.

• India pharma market size, global rank, 3,000+ companies and 10,500 units: Press Information Bureau (Government of India), March 2026
• Pharma export trend and 2026 sector overview: IBEF Pharmaceuticals Infographic, February 2026
• USD 30.47 billion exports in FY 2024-25 and 9.4% growth: IANS report via Lokmat Times, March 2026
• 8–10% domestic growth outlook for FY2026: ICRA commentary via India Med Today
• Kerala’s 20.7% elderly population (NFHS-6), 20.3% under-15 share and RBI projection: Onmanorama, June 2026
• Rising obesity and blood sugar in Kerala (NFHS-6): Onmanorama Health, 2026
• Diabetes (34.75%) and hypertension (53.24%) among Kerala’s elderly (LASI): Onmanorama, 2025
• NSS 80th Round health survey findings and Kerala’s 22.8% elderly projection for 2036: The South First, April 2026 and The South First, May 2026
• Original survey data: NFHS-6 (International Institute for Population Sciences and the Ministry of Health and Family Welfare), NSS 80th Round (MoSPI) and the RBI report State Finances: A Study of Budgets of 2025-26.